Literature DB >> 1527406

Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.

C A Robertson1, J Y Mok, K S Froebel, P Simmonds, S M Burns, H S Marsden, S Graham.   

Abstract

A retrospective study of sera from mothers infected with human immunodeficiency virus (HIV-1) was undertaken to investigate whether the titers or affinities of antibodies against the third hypervariable region (V3 loop) of gp120 correlated with transmission of the virus from mother to child. The cohort comprised 7 mothers who transmitted HIV-1 to their children and 20 who did not. Sera were screened for reactivity against two synthetic peptides, one encompassing the entire V3 loop of gp120 (amino acids 297-330) and the other containing an immunodominant epitope from gp41 (amino acids 596-614). Doubling dilutions of sera were tested to obtain antibody titers against both peptides: Anti-gp41 titers were used to normalize the anti-V3 titers. Maternal sera were also screened for the presence of high-affinity antibodies against the V3 peptide. No differences were observed in either titers or affinities of maternal antibodies to the V3 sequence from transmitters and nontransmitters.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527406     DOI: 10.1093/infdis/166.4.704

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

2.  Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS.

Authors:  C V Fletcher; B K Goodroad; L M Cummins; K Henry; H H Balfour; F S Rhame
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 3.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.

Authors:  C C Wilson; R C Brown; B T Korber; B M Wilkes; D J Ruhl; D Sakamoto; K Kunstman; K Luzuriaga; I C Hanson; S M Widmayer; A Wiznia; S Clapp; A J Ammann; R A Koup; S M Wolinsky; B D Walker
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission.

Authors:  R Narwa; P Roques; C Courpotin; F Parnet-Mathieu; F Boussin; A Roane; D Marce; G Lasfargues; D Dormont
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates.

Authors:  P P Reinhardt; B Reinhardt; J L Lathey; S A Spector
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

9.  The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.

Authors:  D Chargelegue; C M Stanley; C M O'Toole; B T Colvin; M W Steward
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

10.  Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants.

Authors:  A Mabondzo; P Rouvier; H Raoul; R Le Naour; C Courpotin; F Hervé; F Parnet-Mathieu; G Lasfargues; D Dormont
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.